Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The human cell lines (HCT116, COS-1, HaCaT and LNCaP) were provided by the RIKEN BRC.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells

Study design awaiting verification · PLOS ONE · 2023

Original publication title

Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells

Miho Iwaki; Yoshiaki Kanemoto; Takahiro Sawada; Koki Nojiri; Tomohiro Kurokawa; Rino Tsutsumi; Kazuo Nagasawa; Shigeaki Kato

© 2023 Iwaki et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vitamin D (VD) exerts a wide variety of biological functions including calcemic activity. VD nutritional status is closely associated with the onset and development of chronic diseases. To develop a VD analog with the desired VD activity but without calcemic activity, we screened synthetic VDR antagonists. We identified 1α,25-dihydroxyvitamin D3-26-23-lactams (DLAM)-2a-d (DLAM-2s) as nuclear vitamin D receptor (VDR) ligands in a competitive VDR binding assay for 1α,25(OH)2 vitamin D3 (1α,25(OH)2D3), and DLAM-2s showed an antagonistic effect on 1α,25(OH)2 D3-induced cell differentiation in HL60 cells.

In a luciferase reporter assay in which human VDR was exogenously expressed in cultured COS-1 cells, DLAM-2s acted as transcriptional antagonists. Consistently, DLAM-2s had an antagonistic effect on the 1α,25(OH)2D3-induced expression of a known VD target gene [Cytochrome P450 24A1 (CYP24A1)], and VDR bound DLAM-2s was recruited to an endogenous VD response element in chromatin in human keratinocytes (HaCaT cells) endogenously expressing VDR. In an ATAC-seq assay, the effects of 1α,25(OH)2 D3 and DLAM-2b on chromatin reorganization were undetectable in HaCaT cells, while the effect of an androgen receptor (AR) antagonist (bicalutamide) was confirmed in prostate cancer cells (LNCaP) expressing endogenous AR.

However, whole genome analysis using RNA-seq and ATAC (Assay for Transposase Accessible Chromatin)-seq revealed differential gene expression profiles regulated by DLAM-2b versus 1α,25(OH)2D3. The upregulated and downregulated genes only partially overlapped between cells treated with 1α,25(OH)2D3 and those treated with DLAM-2b. Thus, the present findings illustrate a novel VDR ligand with gene regulatory activity differing from that of 1α,25(OH)2D3.

Authors’ abstract

Vitamin D (VD) exerts a wide variety of biological functions including calcemic activity. VD nutritional status is closely associated with the onset and development of chronic diseases. To develop a VD analog with the desired VD activity but without calcemic activity, we screened synthetic VDR antagonists. We identified 1α,25-dihydroxyvitamin D3-26-23-lactams (DLAM)-2a-d (DLAM-2s) as nuclear vitamin D receptor (VDR) ligands in a competitive VDR binding assay for 1α,25(OH)2 vitamin D3 (1α,25(OH)2D3), and DLAM-2s showed an antagonistic effect on 1α,25(OH)2 D3-induced cell differentiation in HL60 cells.

In a luciferase reporter assay in which human VDR was exogenously expressed in cultured COS-1 cells, DLAM-2s acted as transcriptional antagonists. Consistently, DLAM-2s had an antagonistic effect on the 1α,25(OH)2D3-induced expression of a known VD target gene [Cytochrome P450 24A1 (CYP24A1)], and VDR bound DLAM-2s was recruited to an endogenous VD response element in chromatin in human keratinocytes (HaCaT cells) endogenously expressing VDR. In an ATAC-seq assay, the effects of 1α,25(OH)2 D3 and DLAM-2b on chromatin reorganization were undetectable in HaCaT cells, while the effect of an androgen receptor (AR) antagonist (bicalutamide) was confirmed in prostate cancer cells (LNCaP) expressing endogenous AR.

However, whole genome analysis using RNA-seq and ATAC (Assay for Transposase Accessible Chromatin)-seq revealed differential gene expression profiles regulated by DLAM-2b versus 1α,25(OH)2D3. The upregulated and downregulated genes only partially overlapped between cells treated with 1α,25(OH)2D3 and those treated with DLAM-2b. Thus, the present findings illustrate a novel VDR ligand with gene regulatory activity differing from that of 1α,25(OH)2D3.

Publication and source details

Original title: Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells

Miho Iwaki; Yoshiaki Kanemoto; Takahiro Sawada; Koki Nojiri; Tomohiro Kurokawa; Rino Tsutsumi; Kazuo Nagasawa; Shigeaki Kato

PLOS ONE · 2023

Competing Interests: No

* E-mail: shigeaki.kato@isu.ac.jp, uskato0525@gmail.com
© 2023 Iwaki et al2023Iwaki et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The Tokiwa Foundation and The practical development projects by Fukushima prefecture https://orcid.org/0000-0002-5564-1695 Kato Shigeaki http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science #19K08925 Nagasawa Kazuo http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science #22K19101 Nagasawa Kazuo http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science #23K14350 Nojiri Koki http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science #23K15502 https://orcid.org/0000-0002-7932-8724 Kurokawa Tomohiro JSPS KAKENHI #22K19101 to K. Nagasawa, #23K14350 to K. Nojiri, and #23K15502 to T.K. 1) JSPS KAKENHI by The Ministry of Education, Culture, Sports, Science and Technology of Japan To K. Nagasawa (K. N.) (#22K19101): conceptualized and designed the study as well as supervised the manuscript writing. To K. Nojiri (K. N.) (#23K14350): conducted the experiments and analyzed and interpreted the data. To T. Kurokawa (#23K15502): analyzed and interpreted the data. 2) The Tokiwa Foundation and The practical development projects by Fukushima prefecture. To S. Kato conceptualized and designed the study as well as supervised the manuscript writing.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:37:28.404122+00:00

DOI: 10.1371/journal.pone.0295288 · PMC10718451